Cantourage Group SE shows strong business performance and high growth
momentum in the first half of 2024

EQS-News: Cantourage Group SE / Key word(s): Half Year Results
Cantourage Group SE shows strong business performance and high growth
momentum in the first half of 2024

09.07.2024 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Not for release, publication or distribution, directly or indirectly, in or
into the United States of America, Australia, Canada or Japan or any other
jurisdiction in which such release, publication or distribution would be
unlawful. The important notes at the end of this announcement need to be
observed.

Cantourage Group SE shows strong business performance and high growth
momentum in the first half of 2024

  * Significant increase in sales revenue to EUR 16.9 million in the first
    half of 2024 (prior-year period: EUR 11.1 million)

  * The main drivers of the strong growth in revenue were in particular the
    positive development of business activities in Germany and the
    international business of Cantourage Group SE

* Further dynamic growth expected for the second half of 2024

Berlin, July 09, 2024 - Cantourage Group SE (hereinafter "Cantourage," ISIN:
DE000A3DSV01, www.cantourage.com), a leading European cannabis production
and distribution company, significantly increased its sales revenue to EUR
16.9 million in the first half of 2024, a 52% increase compared to the first
half of 2023 (H1 2023 revenues: EUR 11.1 million). The highest monthly
revenue in the current year to date was generated in June 2024 at EUR 4.1
million, followed by EUR 3.5 million in May 2024 and EUR 3.2 million in
April 2024. Sales revenue therefore increased to a total of EUR 10.8 million
in the second quarter of 2024, up from EUR 6.1 million in the first quarter
of 2024. Overall, Cantourage generated higher revenues in the first half of
2024 than in the entire 2022 fiscal year (full-year 2022 revenues: EUR 14.2
million).

The main drivers of the growth in revenue in the first half of 2024 were the
expansion of the cannabis flower business in Germany on the one hand and the
overall positive development of business activities in Cantourage's various
European target markets on the other. In the first six months of 2024,
Cantourage launched 15 new cannabis flower-based products from 10
cultivation partners. This enabled Cantourage to respond quickly and
comprehensively to the changing cannabis demand from patients in the
European target markets. In Germany, demand for high-quality cannabis
products skyrocketed following the partial legalization of cannabis in April
2024. In addition to strong growth in the German market, Cantourage also
benefited from strong growth momentum in the UK in the first half of 2024.
Cantourage's UK business unit is now one of the largest and fastest growing
cannabis companies in the UK.

Philip Schetter, CEO of Cantourage: "Our company was able to develop really
well in the first half of 2024. Of course, the partial legalization of
cannabis in Germany in particular played into our hands as expected. We had
prepared ourselves comprehensively and in good time for the respective legal
changes. This enabled us to quickly benefit from the changed framework
conditions and lay the key foundations for further dynamic growth in the
second half of 2024. We have recently significantly expanded our production
capacities in particular - firstly by expanding our own production facility
and secondly through a strategic partnership with the Portuguese company
Portocanna. Cantourage's total capacity to bring cannabis flowers to its
European target markets has thus increased from a maximum of eight to up to
14 tons per year. In general, we expect the increase in cannabis patients in
Germany, the UK and other European countries to continue in the coming
months - and years. We also firmly believe that our network of premium
growers, pharmacies and wholesalers will continue to grow in the future. We
have an intact and scalable system from which not only we but also our
cooperation partners benefit. Accordingly, I believe there are still many
reasons to be very optimistic about Cantourage's future."

About Cantourage

Cantourage is a leading European producer and distributor of cannabis
flowers and cannabis-based medicinal preparations and drugs. The
Berlin-based company was founded in 2019 by industry pioneers Norman
Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffmann. With an experienced
management team and its "Fast TrackAccess" platform, Cantourage enables
producers from around the world to become part of the growing European
medical cannabis market faster, easier and more cost-effectively by
processing and distributing their cannabis raw materials and extracts. In
this context, Cantourage ensures compliance with the highest European
pharmaceutical quality standards at all times. The company offers
pharmaceutical-grade products in all relevant market segments: dried
flower,extracts, dronabinol and cannabidiol. Cantourage was listed on the
Frankfurt Stock Exchange on 11 November 2022 and is listed under ticker
symbol "HIGH."

Further information: www.cantourage.com

This announcement does not constitute a public offer or an advertisement for
a public offer to sell securities, in particular not within the meaning of
Regulation (EU) 2017/1129 (Prospectus Regulation).

Press Contact at Cantourage:

Frederick Steudemann

Phone: +49 (0)30 4701 350 - 50

steudemann@cantourage.com


---------------------------------------------------------------------------

09.07.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        Cantourage Group SE
                   Feurigstraße 54
                   10827 Berlin
                   Germany
   E-mail:         info@cantourage.com
   Internet:       https://www.cantourage.com/
   ISIN:           DE000A3DSV01
   WKN:            A3DSV0
   Listed:         Regulated Unofficial Market in Berlin, Dusseldorf,
                   Frankfurt (Scale), Munich, Stuttgart, Tradegate
                   Exchange
   EQS News ID:    1941777

End of News EQS News Service
---------------------------------------------------------------------------

1941777 09.07.2024 CET/CEST